| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP & CFO | EVP, CFO & Chief Admin Officer | SVP, Finance & Treasury, & CFO +1 more
3 companies
Matthew E Garth last filed a Form 4 in October 2025, as EVP & CFO at XRAY. The filings on record cover 3 companies. Matthew E Garth's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 29,179 shares of SMG.
Matthew E Garth has 34 Form 4 filings on record from January 2018 to October 2025, across 3 companies: EVP & CFO at Dentsply Sirona (XRAY), 2025; EVP, CFO & Chief Admin Officer at Scotts Miracle-Gro (SMG), 2022–2024; SVP, Finance & Treasury, & CFO at Minerals Technologies (MTX), 2018–2022.
The 55 reported transactions were 16 option or other derivative awards, 14 tax withholdings, 11 option exercises and 7 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $6K and no sales.
The only open-market purchase was 100 shares of MTX at an average $63.75 on March 7, 2022, about $6K. Twelve months later MTX was down 3%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | MTX Minerals Technologies Inc | SVP, Finance & Treasury, & CFO | Buy | 100 | $63.75 | $6,375.00 | +0.7% | +9.6% | -3.4% |